content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001628098</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001816736</issuerCik>
        <issuerName>Disc Medicine, Inc.</issuerName>
        <secFileNumber>001-39438</secFileNumber>
        <issuerAddress>
          <com:street1>321 ARSENAL STREET, SUITE 101</com:street1>
          <com:city>WATERTOWN</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02472</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>(617) 674-9274</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Atlas Venture Fund X, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Shareholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Merrill Lynch</name>
          <address>
            <com:street1>One Bryant Park</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10036</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>53215</noOfUnitsSold>
        <aggregateMarketValue>3232279.10</aggregateMarketValue>
        <noOfUnitsOutstanding>34634295</noOfUnitsOutstanding>
        <approxSaleDate>07/23/2025</approxSaleDate>
        <securitiesExchangeName>Nasdaq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>05/01/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Private Placement</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>53215</amountOfSecuritiesAcquired>
        <paymentDate>05/01/2020</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Atlas Venture Fund X, L.P.</name>
          <address>
            <com:street1>300 Technology Sq Ste 8</com:street1>
            <com:city>Cambridge</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02139</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <saleDate>07/18/2025</saleDate>
        <amountOfSecuritiesSold>1184</amountOfSecuritiesSold>
        <grossProceeds>72375.20</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Atlas Venture Opportunity Fund I, LP.</name>
          <address>
            <com:street1>300 Technology Sq Ste 8</com:street1>
            <com:city>Cambridge</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02139</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <saleDate>07/18/2025</saleDate>
        <amountOfSecuritiesSold>664</amountOfSecuritiesSold>
        <grossProceeds>40588.80</grossProceeds>
      </securitiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>07/23/2025</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>01/31/2025</planAdoptionDate>
        </planAdoptionDates>
        <signature>Ommer Chohan</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4052}]
text: 144
  0001628098
  XXXXXXXX
  LIVE
  0001816736
  Disc Medicine, Inc.
  001-39438
  321 ARSENAL STREET, SUITE 101
  WATERTOWN
  MA
  02472
  (617) 674-9274
  Atlas Venture Fund X, L.P.
  Shareholder
  Common Stock
  Merrill Lynch
  One Bryant Park
  New York
  NY
  10036
  53215
  3232279.10
  34634295
  07/23/2025
  Nasdaq
  Common Stock
  05/01/2020
  Private Placement
  Issuer
  N
  53215
  05/01/2020
  Cash
  N
  Atlas Venture Fund X, L.P.
  300 Technology Sq Ste 8
  Cambridge
  MA
  02139
  Common Stock
  07/18/2025
  1184
  72375.20
  Atlas Venture Opportunity Fund I, LP.
  300 Technology Sq Ste 8
  Cambridge
  MA
  02139
  Common Stock
  07/18/2025
  664
  40588.80
  07/23/2025
  01/31/2025
  Ommer Chohan